Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Equity Ratio (2021 - 2025)

Verrica Pharmaceuticals has reported Equity Ratio over the past 5 years, most recently at 0.52 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.52 for Q4 2025, up 388.23% from a year ago — trailing twelve months through Dec 2025 was 0.52 (up 388.23% YoY), and the annual figure for FY2025 was 0.52, up 388.23%.
  • Equity Ratio for Q4 2025 was 0.52 at Verrica Pharmaceuticals, up from 0.42 in the prior quarter.
  • Over the last five years, Equity Ratio for VRCA hit a ceiling of 0.94 in Q1 2023 and a floor of 1.03 in Q3 2024.
  • Median Equity Ratio over the past 5 years was 0.38 (2021), compared with a mean of 0.23.
  • Peak annual rise in Equity Ratio hit 388.23% in 2025, while the deepest fall reached 2036.53% in 2025.
  • Verrica Pharmaceuticals' Equity Ratio stood at 0.41 in 2021, then skyrocketed by 119.98% to 0.9 in 2022, then plummeted by 72.94% to 0.24 in 2023, then tumbled by 175.2% to 0.18 in 2024, then surged by 388.23% to 0.52 in 2025.
  • The last three reported values for Equity Ratio were 0.52 (Q4 2025), 0.42 (Q3 2025), and 0.45 (Q2 2025) per Business Quant data.